Literature DB >> 29927469

Risk Factors for Retinal Redetachment After Silicone Oil Removal: A Systematic Review and Meta-Analysis.

Yueqing He, Shaoxue Zeng, Yunni Zhang, Junjun Zhang.   

Abstract

BACKGROUND AND
OBJECTIVE: This systematic review and meta-analysis was made to measure risk factors for retinal redetachment (re-RD) after silicone oil removal (SOR) in a quantitative method. PATIENTS AND METHODS: A comprehensive literature review relating to risk factors for re-RD after SOR was conducted before March 2017. Odds ratio (OR) with 95% confidence interval (CI) was calculated after data combination.
RESULTS: Sixteen studies were included, and risk factors with significant differences found between the re-RD and control groups are as follows: aphakic eye (OR = 1.50), high myopia (OR = 2.47), previous failed retinal surgery (OR = 1.71), and ocular trauma (OR = 3.52). Peripheral 360° laser retinopexy (OR = 0.40) and scleral encircling band (OR = 0.58) were found to be protective factors of re-RD after SOR.
CONCLUSION: Aphakic eye, high myopia, previous failed retinal surgery, ocular trauma, lack of 360° laser, and scleral encircling band were possible risk factors relating to the occurrence of re-RD after SOR. [Ophthalmic Surg Lasers Imaging Retina. 2018;49:416-424.].
© 2018 He, Zeng, Zhang, et al.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29927469     DOI: 10.3928/23258160-20180601-06

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  2 in total

1.  Surgical outcomes in inferior recurrences of rhegmatogenous retinal detachment.

Authors:  Sergey V Churashov; Tatiana N Shevalova; Alexei N Kulikov; Dmitrii S Maltsev
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

2.  Protective Role of 360° Laser Retinopexy in Patients with Rhegmatogenous Retinal Detachment: a Systematic Review and Meta-analysis.

Authors:  Christa Soekamto; Edward R Chu; Daniel A Johnson; Jeong-Hyeon Sohn; Sepehr Bahadorani
Journal:  Korean J Ophthalmol       Date:  2021-06-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.